secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nautilus Biotechnology, Inc. (NAUT)
CIK:        0001808805
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0001628280-24-007395
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nautilus Biotechnology enters $125M at-the-market equity offering with TD Cowen
-------------------------------------------------------------------------------

- Sales agreement with TD Cowen to sell up to $125M of common stock via ATM program.
- TD Cowen will receive up to 3.0% of gross proceeds as compensation.
- Company may set sale parameters including price, volume, and timing; no obligation to sell.
- Shares issued under S-3 registration statement filed Feb 28, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808805/000162828024007395/0001628280-24-007395-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808805/000162828024007395/naut-20240228.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-007395

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer